Magnetic Resonance Cancer Nanotheranostics

被引：2

作者：

Orel, V. E. ^{[1
,2
]}

Tselepi, M. ^{[3
,8
]}

Mitrelias, T. ^{[3
]}

Shevchenko, A. D. ^{[4
]}

Rykhalskiy, O. Y. ^{[1
,2
]}

Golovko, T. S. ^{[5
]}

Ganich, O. V. ^{[5
]}

Romanov, A. V. ^{[1
]}

Orel, V. B. ^{[6
]}

Burlaka, A. P. ^{[7
]}

Lukin, S. N. ^{[7
]}

Barnes, C. H. W. ^{[3
]}

机构：

[1] Natl Canc Inst, Med Phys & Bioengn Res Lab, Kiev, Ukraine

[2] Igor Sikorsky Kyiv Polytech Inst, Dept Biomed Engn, Kiev, Ukraine

[3] Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge, England

[4] GV Kurdyumov Inst Met Phys, Kiev, Ukraine

[5] Natl Canc Inst, Res Dept Radiodiagnost, Kiev, Ukraine

[6] Bogomolets Natl Med Univ, Kiev, Ukraine

[7] NAS Ukraine, RE Kavetsky Inst Expt Pathol Oncol & Radiobiol, Kiev, Ukraine

[8] Univ Ioannina, Dept Phys, Ioannina, Greece

来源：

WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING 2018, VOL 3 | 2019年 / 68卷 / 03期

关键词：

Magnetic resonance; Magnetic nanocomplex; Doxorubicin; Tumor;

D O I：

10.1007/978-981-10-9023-3_120

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

It is well known that the magnetic spin effects during nanotherapy can cause tumor cell apoptosis and necrosis based on redox reactions. The current study was carried out on C57Bl/6 mice with Lewis lung carcinoma. The magnetic nanocomplex administration combined with the impact of magnetic resonance system (1.5 T) showed maximal antitumor and antimetastatic effects. The electron spin resonance spectra have been used as diagnostic markers and recorded a change in the tumor redox state based on chemical species such as NO-FeS-proteins and ubisemiquinone. The technology of magnetic resonance nanotheranostics could potentially allow to improve the antitumor effect of chemotherapeutic agents in disseminated cancer therapy.

引用

页码：651 / 654

页数：4

共 50 条

[31] Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer
Huzjan, R
Sala, E
Hricak, H
NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (09): : 434 - 442
[32] Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis
Kundu, Paromita
Singh, Deepika
Singh, Abhalaxmi
Sahoo, Sanjeeb K.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2020, 20 (11) : 1288 - 1299
[33] Ultrasound nanotheranostics in fighting cancer: Advances and prospects
Zhou, Li-Qiang
Li, Pan
Cui, Xin-Wu
Dietrich, Christoph F.
CANCER LETTERS, 2020, 470 : 204 - 219
[34] Chemical Modification of Chitosan for Developing Cancer Nanotheranostics
Li, Xudong
Wang, Yuran
Feng, Chenyun
Chen, Haijun
Gao, Yu
BIOMACROMOLECULES, 2022, 23 (06) : 2197 - 2218
[35] Rational design of high performance nanotheranostics for NIR-II fluorescence/magnetic resonance imaging guided enhanced phototherapy†
Wang, Qi
Cai, Jie
Niu, Xinrui
Wang, Jing
Liu, Jiawei
Xie, Chen
Huang, Wei
Fan, Quli
BIOMATERIALS SCIENCE, 2021, 9 (09) : 3499 - 3506
[36] Doxorubicin delivery by magnetic nanotheranostics enhances the cell death in chemoresistant colorectal cancer-derived cells
Martin, Maria Julia
Azcona, Pamela
Lassalle, Veronica
Gentili, Claudia
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 158
[37] Localized nanotheranostics: recent developments in cancer nanomedicine
Prasad, R.
Jain, N. K.
Conde, J.
Srivastava, R.
MATERIALS TODAY ADVANCES, 2020, 8
[38] Two-Dimensional Nanomaterials for Cancer Nanotheranostics
Chen, Yongjiu
Wu, Yakun
Sun, Bingbing
Liu, Sijin
Liu, Huiyu
SMALL, 2017, 13 (10)
[39] Nanotheranostics for Cancer Therapy and Detection: State of the Art
Paliwal, Shivani Rai
Kenwat, Rameshroo
Maiti, Sabyasachi
Paliwal, Rishi
CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (42) : 5503 - 5517
[40] Nanotheranostics for Image-Guided Cancer Treatment
Dennahy, Isabel S.
Han, Zheng
MacCuaig, William M.
Chalfant, Hunter M.
Condacse, Anna
Hagood, Jordan M.
Claros-Sorto, Juan C.
Razaq, Wajeeha
Holter-Chakrabarty, Jennifer
Squires, Ronald
Edil, Barish H.
Jain, Ajay
McNally, Lacey R.
PHARMACEUTICS, 2022, 14 (05)

← 1 2 3 4 5 →